CryoLife Ownership
CYL Stock | EUR 26.75 0.10 0.38% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
CryoLife |
CryoLife Stock Ownership Analysis
About 87.0% of the company shares are held by institutions such as insurance companies. The book value of CryoLife was currently reported as 7.05. The company has Price/Earnings (P/E) ratio of 303.28. CryoLife recorded a loss per share of 0.44. The entity last dividend was issued on the 9th of December 2015. The firm had 3:2 split on the 28th of December 2000. CryoLife, Inc., together with its subsidiaries, manufactures, processes, and distributes medical devices and implantable human tissues for use in cardiac and vascular surgeries worldwide. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia. CRYOLIFE INC operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 1100 people. For more info on CryoLife please contact the company at 770 419 3355 or go to https://artivion.com.CryoLife Outstanding Bonds
CryoLife issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. CryoLife uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most CryoLife bonds can be classified according to their maturity, which is the date when CryoLife has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Boeing Co 2196 Corp BondUS097023DG73 | View | |
Morgan Stanley 3591 Corp BondUS61744YAK47 | View | |
Morgan Stanley 3971 Corp BondUS61744YAL20 | View |
Currently Active Assets on Macroaxis
Other Information on Investing in CryoLife Stock
CryoLife financial ratios help investors to determine whether CryoLife Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CryoLife with respect to the benefits of owning CryoLife security.